A Phase II/III, Double-blind, Randomized, Placebo-controlled Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection
The aim of this study is to assess the efficacy of the RUTI® vaccine in achieving clinical improvement of COVID-19 symptoms and to evaluate the safety of RUTI® in patients with SARS-CoV-2 infection. The study will include a comparison between placebo and RUTI® vaccine in a 1:1 design.
100 项与 PT. Innovative Pharma Solutions 相关的临床结果
0 项与 PT. Innovative Pharma Solutions 相关的专利（医药）
100 项与 PT. Innovative Pharma Solutions 相关的药物交易
100 项与 PT. Innovative Pharma Solutions 相关的转化医学
